Compare · MASI vs PRKS
MASI vs PRKS
Side-by-side comparison of Masimo Corporation (MASI) and United Parks & Resorts Inc. (PRKS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MASI and PRKS operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- MASI is the larger of the two at $9.42B, about 4.2x PRKS ($2.23B).
- Over the past year, MASI is up 7.1% and PRKS is up 3.1% - MASI leads by 4.0 points.
- MASI has been more active in the news (27 items in the past 4 weeks vs 16 for PRKS).
- MASI has more recent analyst coverage (24 ratings vs 6 for PRKS).
- Company
- Masimo Corporation
- United Parks & Resorts Inc.
- Price
- $179.96+0.00%
- $46.65+1.72%
- Market cap
- $9.42B
- $2.23B
- 1M return
- +0.93%
- +33.61%
- 1Y return
- +7.07%
- +3.07%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NYSE
- IPO
- 2007
- 2013
- News (4w)
- 27
- 16
- Recent ratings
- 24
- 6
Masimo Corporation
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. The company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. The company offers coronavirus-2019 response and telehealth solutions; connectivity devices; and nasal high flow ventilation and neuromodulation solutions. The company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, physician offices, long term care facilities, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. Incorporated in 1989, the company is headquartered in Irvine, California.
Latest MASI
- Director Solomon Darlene J. S. returned $542,700 worth of shares to the company (3,015 units at $180.00), closing all direct ownership in the company (SEC Form 4)
- Director Scannell Timothy J returned $469,440 worth of shares to the company (2,608 units at $180.00), closing all direct ownership in the company (SEC Form 4)
- Director Lane Wendy E returned $469,440 worth of shares to the company (2,608 units at $180.00), closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Director by deputization Politan Capital Management Lp
- Director by deputization Politan Capital Management Lp returned $826,357,140 worth of shares to the company (4,590,873 units at $180.00) (SEC Form 4)
- Chairman of the Board Brennan Michelle returned $1,675,620 worth of shares to the company (9,309 units at $180.00), closing all direct ownership in the company (SEC Form 4)
- SVP, Chief Accounting Officer Hataishi Paul returned $2,397,060 worth of shares to the company (13,317 units at $180.00), closing all direct ownership in the company (SEC Form 4)
- EVP, Operations Sampath Anand returned $6,102,180 worth of shares to the company (33,901 units at $180.00), closing all direct ownership in the company (SEC Form 4) to cover taxes
- SEC Form 4 filed by Chief Commercial Officer Meehan Greg Allen (for tax liability)
- Chief Human Resources Officer Hellmann Elisabeth A returned $38,520 worth of shares to the company (214 units at $180.00), closing all direct ownership in the company (SEC Form 4) (for tax liability)
Latest PRKS
- Director Maruyama Yoshikazu was granted 5,404 shares, increasing direct ownership by 11% to 53,145 units (SEC Form 4)
- Large owner Hill Path Capital Partners Co-Investment S Lp was granted 5,404 shares (SEC Form 4)
- Director Moloney Thomas E was granted 5,404 shares, increasing direct ownership by 7% to 86,399 units (SEC Form 4)
- Large owner Hill Path Capital Partners Lp was granted 5,404 shares (SEC Form 4)
- Director Lipman Nathaniel was granted 5,404 shares, increasing direct ownership by 37% to 20,109 units (SEC Form 4)
- Director Chambers James P. was granted 5,404 shares, increasing direct ownership by 9% to 64,460 units (SEC Form 4)
- Director Gray William was granted 5,404 shares, increasing direct ownership by 8% to 75,463 units (SEC Form 4)
- Director Hartnett Timothy was granted 5,404 shares, increasing direct ownership by 7% to 79,557 units (SEC Form 4)
- Director Narang Neha Jogani was granted 5,404 shares, increasing direct ownership by 11% to 56,546 units (SEC Form 4)
- Director Schaefer Kimberly was granted 5,404 shares, increasing direct ownership by 15% to 42,325 units (SEC Form 4)